These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11903928)
1. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains. Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928 [TBL] [Abstract][Full Text] [Related]
2. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain. von Holst H; Nygren C; Boström K; Collins VP; Fredman P Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo. Wikstrand CJ; He XM; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882 [TBL] [Abstract][Full Text] [Related]
4. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Wikstrand CJ; Fredman P; McLendon RR; Svennerholm L; Bigner DD Mol Chem Neuropathol; 1994; 21(2-3):129-38. PubMed ID: 7522005 [TBL] [Abstract][Full Text] [Related]
5. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092 [TBL] [Abstract][Full Text] [Related]
6. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. Fredman P Prog Brain Res; 1994; 101():225-40. PubMed ID: 8029453 [TBL] [Abstract][Full Text] [Related]
7. Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors. Fredman P; von Holst H; Collins VP; Dellheden B; Svennerholm L J Neurochem; 1993 Jan; 60(1):99-105. PubMed ID: 8417168 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of gangliosides in ENU-induced rat glioma. Takeshima F; Iwasaki K; Shimokawa I; Ikeda T; Matsuo T Acta Pathol Jpn; 1992 Aug; 42(8):558-65. PubMed ID: 1449052 [TBL] [Abstract][Full Text] [Related]
10. [Spectrum pattern and determination of ganglioside from human primary liver cancer of different origins]. Lin ZY Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):336-8. PubMed ID: 2276322 [TBL] [Abstract][Full Text] [Related]
12. In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line. Fredman P; Wikstrand CJ; Månsson JE; Reifenberger G; Bigner SH; Rasheed A; Svennerholm L; Bigner DD Glycoconj J; 1996 Jun; 13(3):391-9. PubMed ID: 8781970 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro. Hedberg KM; Dellheden B; Wikstrand CJ; Fredman P Glycoconj J; 2000 Oct; 17(10):717-26. PubMed ID: 11425192 [TBL] [Abstract][Full Text] [Related]
14. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. Brezicka T; Bergman B; Olling S; Fredman P Lung Cancer; 2000 Apr; 28(1):29-36. PubMed ID: 10704706 [TBL] [Abstract][Full Text] [Related]
15. Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading. Wagener R; Röhn G; Schillinger G; Schröder R; Kobbe B; Ernestus RI Acta Neurochir (Wien); 1999; 141(12):1339-45. PubMed ID: 10672306 [TBL] [Abstract][Full Text] [Related]
16. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells. Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280 [TBL] [Abstract][Full Text] [Related]
17. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. Kawashima I; Ozawa H; Kotani M; Suzuki M; Kawano T; Gomibuchi M; Tai T J Biochem; 1993 Aug; 114(2):186-93. PubMed ID: 8262898 [TBL] [Abstract][Full Text] [Related]
18. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818 [TBL] [Abstract][Full Text] [Related]
19. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo. Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736 [TBL] [Abstract][Full Text] [Related]
20. Ganglioside mapping of a human medulloblastoma xenograft. Gottfries J; Mansson JE; Fredman P; Wikstrand CJ; Friedman HS; Bigner DD; Svennerholm L Acta Neuropathol; 1989; 77(3):283-8. PubMed ID: 2922991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]